Ledger.Open graph →
SEC Form D · filed February 3, 2014

Spring Bank Pharmaceuticals, Inc

Offering
$6.3M
Sold
$6.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MILFORD, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

David E. Arkowitz · Milford, MADirectorRadhakrishnan P. Iyer · Milford, MAExec · DirectorJonathan E. Bates · Milford, MADirectorDouglas J. Jensen · Milford, MAExec · DirectorGuy P. Macdonald · Milford, MADirectorMichael F. Cronin · Milford, MAExecDonald M. Mitchell · Milford, MAExecNezam E. Afdhal · Milford, MAExecGregg E. Beloff · Milford, MAExecChris Joyce · Chelmsford, MAExecRoss Haghighat · Chelmsford, MADirectorKatherine D. Furman · IRVING, TXExec · DirectorBenjamin Liu · Bellevue, WADirectorJames Sun · Bellevue, WAExec · DirectorLinda P. O'Keefe · Pittsboro, INExecGuy P. Macdonald · Milford, MADirectorNezam E. Afdhal · Milford, MAExecGregg E. Beloff · Milford, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗